Mary Elizabeth Strek to Phosphodiesterase Inhibitors
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Phosphodiesterase Inhibitors.
Connection Strength
0.066
-
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest. 2006 Jan; 129(1):56-66.
Score: 0.066
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.